EVOLENT HEALTH INC's ticker is EVH and the CUSIP is 30050B101. A total of 194 filers reported holding EVOLENT HEALTH INC in Q1 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,084,614 | -10.9% | 296,901 | -0.9% | 2.76% | -4.5% |
| Q2 2023 | $9,075,153 | -4.5% | 299,510 | +2.2% | 2.89% | -5.6% |
| Q1 2023 | $9,505,254 | +2.3% | 292,920 | -11.5% | 3.06% | +16.3% |
| Q4 2022 | $9,289,426 | -1.0% | 330,820 | +26.7% | 2.63% | -1.9% |
| Q3 2022 | $9,382,000 | -7.5% | 261,120 | -20.9% | 2.68% | -4.6% |
| Q2 2022 | $10,144,000 | +3.2% | 330,320 | +8.5% | 2.81% | +51.5% |
| Q1 2022 | $9,830,000 | +7.4% | 304,320 | -8.0% | 1.85% | +14.0% |
| Q4 2021 | $9,156,000 | -39.7% | 330,900 | -32.5% | 1.63% | -25.2% |
| Q3 2021 | $15,191,000 | +46.8% | 490,025 | 0.0% | 2.17% | +52.3% |
| Q2 2021 | $10,349,000 | +73.6% | 490,025 | +66.1% | 1.43% | +66.5% |
| Q1 2021 | $5,960,000 | +175.4% | 295,025 | +118.5% | 0.86% | +137.4% |
| Q4 2020 | $2,164,000 | +29.1% | 135,025 | 0.0% | 0.36% | +15.0% |
| Q3 2020 | $1,676,000 | -85.3% | 135,025 | -91.6% | 0.31% | -83.7% |
| Q2 2020 | $11,420,000 | +24.1% | 1,603,930 | -5.3% | 1.93% | +9.6% |
| Q1 2020 | $9,199,000 | -46.7% | 1,694,025 | -11.2% | 1.76% | -19.1% |
| Q4 2019 | $17,268,000 | +38.2% | 1,908,025 | +9.8% | 2.18% | +16.4% |
| Q3 2019 | $12,496,000 | +48.6% | 1,738,025 | +64.3% | 1.87% | +55.9% |
| Q2 2019 | $8,411,000 | +4.8% | 1,058,025 | +65.8% | 1.20% | +6.0% |
| Q1 2019 | $8,026,000 | +224.4% | 638,025 | +414.4% | 1.13% | +178.4% |
| Q4 2018 | $2,474,000 | -29.8% | 124,025 | 0.0% | 0.41% | +0.7% |
| Q3 2018 | $3,522,000 | -83.5% | 124,025 | -87.8% | 0.40% | -82.8% |
| Q2 2018 | $21,406,000 | -25.9% | 1,016,907 | -49.8% | 2.34% | -31.6% |
| Q1 2018 | $28,878,000 | +14.9% | 2,026,530 | -0.8% | 3.42% | +3.6% |
| Q4 2017 | $25,138,000 | +75.8% | 2,043,700 | +154.3% | 3.30% | +47.0% |
| Q3 2017 | $14,302,000 | +461.3% | 803,500 | +699.5% | 2.25% | +413.5% |
| Q2 2017 | $2,548,000 | +74.4% | 100,500 | +53.4% | 0.44% | +43.6% |
| Q1 2017 | $1,461,000 | – | 65,500 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FORMULA GROWTH LTD | 2,026,530 | $28,878,000 | 3.42% |
| Casdin Capital, LLC | 1,110,000 | $15,818,000 | 2.78% |
| Elk Creek Partners, LLC | 2,345,663 | $33,426,000 | 1.95% |
| Chicago Capital, LLC | 859,914 | $12,254,000 | 1.64% |
| Granahan Investment Management | 1,190,958 | $16,971,000 | 1.22% |
| White Pine Investment CO | 165,020 | $2,352,000 | 1.15% |
| RIVERBRIDGE PARTNERS LLC | 2,816,223 | $40,131,000 | 0.73% |
| SECTORAL ASSET MANAGEMENT INC | 423,482 | $6,035,000 | 0.66% |
| Trellus Management Company, LLC | 20,800 | $296,000 | 0.54% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 1,379,647 | $19,660,000 | 0.48% |